Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | DBH | P09172 | 1/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21471512 | 0.93 | MCL1 (0.52) | TYRMMP2DBHTRPA1ACHE | |
| SCHEMBL30894892 | 0.82 | TYR (0.50) | TYRMMP2DBHTRPA1ACHE | |
| SCHEMBL10339603 | 0.77 | TYR (0.54) | TYRMMP2DBHACHETDP1 | |
| SCHEMBL14425214 | 0.72 | TYR (0.50) | TYRMMP2DBHTDP1MEN1 | |
| SCHEMBL21465807 | 0.72 | TYR (0.50) | TYRMMP2DBHTDP1MEN1 | |
| SCHEMBL23250747 | 0.72 | TYR (0.50) | TYRMMP2DBHTDP1MEN1 | |
| SCHEMBL11193755 | 0.72 | TYR (0.56) | TYRMMP2DBHTDP1MEN1 | |
| SCHEMBL916337 | 0.72 | TYR (0.56) | TYRMMP2DBHTDP1MEN1 | |
| SCHEMBL23250710 | 0.72 | HDAC4 (0.56) | TYRTDP1MEN1MAPTKMT2A | |
| SCHEMBL6212439 | 0.72 | HDAC4 (0.55) | TYRMMP2DBHTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018105-A1 | TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS | KINESID THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2021076945-A1 | TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS | Ambys Medicines, Inc. (US) | 2021-04-22 | — | — | WO | disclosed |
| US-9790158-B2 | Substituted tropolone derivatives and methods of use | UNIVERSITY OF CONNECTICUT (US) | 2017-10-17 | — | — | US | disclosed |
| US-20150166448-A1 | Substituted Tropolone Derivatives and Methods of Use | UNIVERSITY OF CONNECTICUT | 2015-06-18 | — | — | US | disclosed |
| EP-1116769-B1 | Electrolyte composition, electrochemical cell and ionic liquid crystal monomer | FUJIFILM CORP (JP) | 2011-12-14 | — | — | EP | disclosed |
| WO-2007101882-A1 | TROPOLONE- AND HYDROXYBENZENE-SUBSTITUTED OLIGOPEPTIDES FOR DEPIGMENTATION | BEIERSDORF AG (DE) | 2007-09-13 | — | — | WO | disclosed |
| US-7259187-B2 | Tropolone derivatives | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2007-08-21 | — | — | US | disclosed |
| US-7259187-B2 | Tropolone derivatives | RESEARCH FOUNDATION ITSUU LABORATORY (JP) | 2007-08-21 | — | — | US | disclosed |
| US-20070185055-A1 | Method for treating cachexia with retinoid ligands | JIANG GUANG LIANG | 2007-08-09 | — | — | US | disclosed |
| US-5003077-A | Having a cycloheptimidazole nucleus; photostability; methine bond having an auxochrome | FUJI PHOTO FILM CO., LTD. (JP) | 1991-03-26 | — | — | US | disclosed |
| US-4900648-A | RECORDING, ERASING USING LASER BEAM, METHINE DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1990-02-13 | — | — | US | disclosed |
| US-4814265-A | CONTAINING METHANE DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1989-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166448-A1 | Substituted Tropolone Derivatives and Methods of Use | HDAC5, HDAC4, HDAC7 | TYR 1992/4885MMP2 680/4885DBH 891/4885 |
| US-20240018105-A1 | TROPOLONE DERIVATIVES AND TAUTOMERS THEREOF FOR IRON REGULATION IN ANIMALS | TXNRD2, TXNRD1, SDHB | TYR 512/4885MMP2 4478/4885DBH 122/4885 |
| US-20070185055-A1 | Method for treating cachexia with retinoid ligands | RXRA, RXRG, RXRB | TYR 4435/4885MMP2 3894/4885DBH 2108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.